Recent advances in the progress of immune checkpoint inhibitors in the treatment of advanced gastric cancer: A review

被引：6

作者：

Shen, Jingjing ^{[1
]}

Wang, Zhongming ^{[2
]}

机构：

[1] Univ Shanghai Sci & Technol, Sch Hlth Sci & Engn, Shanghai, Peoples R China

[2] Univ Shanghai Sci & Technol, Shidong Hosp, Dept Radiat Oncol, Shanghai, Peoples R China

来源：

FRONTIERS IN ONCOLOGY | 2022年 / 12卷

关键词：

gastric cancer; immune checkpoint inhibitors; chemotherapy; targeted therapy; radiotherapy; GASTROESOPHAGEAL JUNCTION CANCER; OPEN-LABEL; SINGLE-ARM; PHASE-II; PLUS PEMBROLIZUMAB; DOUBLE-BLIND; ADENOCARCINOMA; 1ST-LINE; EFFICACY; CHEMOTHERAPY;

D O I：

10.3389/fonc.2022.934249

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Most patients with advanced gastric cancer were treated with palliative therapy, which had a poor curative effect and a short survival time. In recent years, the clinical research of immune checkpoint inhibitors in advanced gastric cancer has made a breakthrough and has become an important treatment for advanced gastric cancer. The modes of immune checkpoint inhibitors in the treatment of advanced gastric cancer include single drug, combined chemotherapy, radiotherapy, and multiple immune drug combination therapy, among which combination therapy shows better clinical efficacy, and a large number of trials are currently exploring more effective combination therapy programs. In this paper, the new clinical research progress of immune checkpoint inhibitors in the treatment of advanced gastric cancer is reviewed, with an emphasis on combination therapy.

引用

页数：12

共 50 条

[21] Clinical efficacy of immune checkpoint inhibitors in the treatment of unresectable advanced or recurrent gastric cancer: an evidence-based review of therapies
Togasaki, Kazuhiro
Sukawa, Yasutaka
Kanai, Takanori
Takaishi, Hiromasa
[J]. ONCOTARGETS AND THERAPY, 2018, 11 : 8239 - 8250
[22] Immunotherapy Based on Immune Checkpoint Molecules and Immune Checkpoint Inhibitors in Gastric Cancer-Narrative Review
Poniewierska-Baran, Agata
Sobolak, Karolina
Niedzwiedzka-Rystwej, Paulina
Plewa, Paulina
Pawlik, Andrzej
[J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (12)
[23] Recent Advances in the Diagnosis, Staging, Treatment, and Prognosis of Advanced Gastric Cancer: A Literature Review
Chen, Zhi-da
Zhang, Peng-Fei
Xi, Hong-Qing
Wei, Bo
Chen, Lin
Tang, Yun
[J]. FRONTIERS IN MEDICINE, 2021, 8
[24] Immune checkpoint inhibitors for treatment of advanced gastric or gastroesophageal junction cancer: Current evidence and future perspectives
Zhening Zhang
Tong Xie
Xiaotian Zhang
Changsong Qi
Lin Shen
Zhi Peng
[J]. Chinese Journal of Cancer Research, 2020, 32 (03) : 287 - 302
[25] Immune checkpoint inhibitors for treatment of advanced gastric or gastroesophageal junction cancer: Current evidence and future perspectives
Zhang, Zhening
Xie, Tong
Zhang, Xiaotian
Qi, Changsong
Shen, Lin
Peng, Zhi
[J]. CHINESE JOURNAL OF CANCER RESEARCH, 2020, 32 (03) : 287 - 302
[26] Recent advances in multimodal treatment for gastric cancer: A review
Lordick F.
Siewert J.R.
[J]. Gastric Cancer, 2005, 8 (2) : 78 - 85
[27] Resistance to immune checkpoint inhibitors in gastric cancer
Liu, Kai
Yuan, Shiman
Wang, Chenyu
Zhu, Hong
[J]. FRONTIERS IN PHARMACOLOGY, 2023, 14
[28] Clinical association of antibiotics in immune checkpoint inhibitors for advanced cancer treatment
Kim, H.
Kim, I-H.
[J]. ANNALS OF ONCOLOGY, 2018, 29
[29] Recent advances in personalized cancer immunotherapy with immune checkpoint inhibitors, T cells and vaccines
Faghfuri, Elnaz
[J]. PERSONALIZED MEDICINE, 2024, 21 (01) : 45 - 57
[30] Immune Checkpoint Inhibitors: Recent Clinical Advances and Future Prospects
Banday, Abid H. H.
Abdalla, Mohnad
[J]. CURRENT MEDICINAL CHEMISTRY, 2023, 30 (28) : 3215 - 3237

← 1 2 3 4 5 →